Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2010

Open Access 01-12-2010 | Case report

Pelvic mass associated with raised CA 125 for benign condition: a case report

Authors: Viren Asher, Robert Hammond, Tim J Duncan

Published in: World Journal of Surgical Oncology | Issue 1/2010

Login to get access

Abstract

Background

Raised CA 125 with associated pelvic mass is highly suggestive of ovarian malignancy, but there are various other benign conditions that can be associated with pelvic mass and a raised CA 125.

Case presentation

We present a case of 19 year old, Caucasian British woman who presented initially with sudden onset right sided iliac fossa pain and on imaging was found to have 9.8 × 4.5 cm complex cystic mass in right adnexa with a raised CA 125 of 657, which was initially thought to be highly suspicious of cancer but was subsequently found to be due to pelvic inflammatory disease on histology.

Conclusion

This case highlights the fact that though a pelvic mass with raised CA 125 is highly suggestive of malignancy, pelvic inflammatory disease should always be considered as a differential diagnosis especially in a young patient and a thorough sexual history and screening for pelvic infection should always be carried out in these patients.
Literature
2.
go back to reference DeVita VTHS, Rosenberg SA: Principles and Practice of Oncology. Edited by: KR Perez CA, Young RC. 1982, Philadelphia: JB Lippioncott, 1982 DeVita VTHS, Rosenberg SA: Principles and Practice of Oncology. Edited by: KR Perez CA, Young RC. 1982, Philadelphia: JB Lippioncott, 1982
3.
go back to reference Westhoff C: Ovarian cancer. Annu Rev Public Health. 1996, 17: 85-96. 10.1146/annurev.pu.17.050196.000505.CrossRefPubMed Westhoff C: Ovarian cancer. Annu Rev Public Health. 1996, 17: 85-96. 10.1146/annurev.pu.17.050196.000505.CrossRefPubMed
4.
go back to reference Bast RC, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths CT, Parker L, Zurawski VR, Knapp RC: A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983, 309 (15): 883-7.CrossRefPubMed Bast RC, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths CT, Parker L, Zurawski VR, Knapp RC: A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983, 309 (15): 883-7.CrossRefPubMed
5.
go back to reference Bast RC, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC: Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981, 68 (5): 1331-7. 10.1172/JCI110380.PubMedCentralCrossRefPubMed Bast RC, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC: Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981, 68 (5): 1331-7. 10.1172/JCI110380.PubMedCentralCrossRefPubMed
6.
go back to reference Jacobs I, Bast RC: The CA 125 tumour-associated antigen: a review of the literature. Hum Reprod. 1989, 4 (1): 1-12.PubMed Jacobs I, Bast RC: The CA 125 tumour-associated antigen: a review of the literature. Hum Reprod. 1989, 4 (1): 1-12.PubMed
7.
go back to reference Malkasian GD, Knapp RC, Lavin PT, Zurawski VR, Podratz KC, Stanhope CR, Mortel R, Berek JS, Bast RC, Ritts RE: Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease. Am J Obstet Gynecol. 1988, 159 (2): 341-6.CrossRefPubMed Malkasian GD, Knapp RC, Lavin PT, Zurawski VR, Podratz KC, Stanhope CR, Mortel R, Berek JS, Bast RC, Ritts RE: Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease. Am J Obstet Gynecol. 1988, 159 (2): 341-6.CrossRefPubMed
8.
go back to reference Chen DX, Schwartz PE, Li XG, Yang Z: Evaluation of CA 125 levels in differentiating malignant from benign tumors in patients with pelvic masses. Obstet Gynecol. 1988, 72 (1): 23-7.PubMed Chen DX, Schwartz PE, Li XG, Yang Z: Evaluation of CA 125 levels in differentiating malignant from benign tumors in patients with pelvic masses. Obstet Gynecol. 1988, 72 (1): 23-7.PubMed
9.
go back to reference Nolen B: Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass. Gynecol Oncol. Nolen B: Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass. Gynecol Oncol.
10.
go back to reference Togashi K: Ovarian cancer: the clinical role of US, CT, and MRI. Eur Radiol. 2003, 13 (Suppl 4): L87-104. 10.1007/s00330-003-1964-y.CrossRefPubMed Togashi K: Ovarian cancer: the clinical role of US, CT, and MRI. Eur Radiol. 2003, 13 (Suppl 4): L87-104. 10.1007/s00330-003-1964-y.CrossRefPubMed
11.
go back to reference Jeong YY, Outwater EK, Kang HK: Imaging evaluation of ovarian masses. Radiographics. 2000, 20 (5): 1445-70.CrossRefPubMed Jeong YY, Outwater EK, Kang HK: Imaging evaluation of ovarian masses. Radiographics. 2000, 20 (5): 1445-70.CrossRefPubMed
12.
go back to reference Balan P: Ultrasonography, computed tomography and magnetic resonance imaging in the assessment of pelvic pathology. Eur J Radiol. 2006, 58 (1): 147-55. 10.1016/j.ejrad.2005.10.002.CrossRefPubMed Balan P: Ultrasonography, computed tomography and magnetic resonance imaging in the assessment of pelvic pathology. Eur J Radiol. 2006, 58 (1): 147-55. 10.1016/j.ejrad.2005.10.002.CrossRefPubMed
13.
go back to reference Liu J, Xu Y, Wang J: Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis of ovarian carcinoma. Eur J Radiol. 2007, 62 (3): 328-34. 10.1016/j.ejrad.2007.02.040.CrossRefPubMed Liu J, Xu Y, Wang J: Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis of ovarian carcinoma. Eur J Radiol. 2007, 62 (3): 328-34. 10.1016/j.ejrad.2007.02.040.CrossRefPubMed
14.
go back to reference Risum S, Høgdall C, Loft A, Berthelsen AK, Høgdall E, Nedergaard L, Lundvall L, Engelholm SA: The diagnostic value of PET/CT for primary ovarian cancer--a prospective study. Gynecol Oncol. 2007, 105 (1): 145-9. 10.1016/j.ygyno.2006.11.022.CrossRefPubMed Risum S, Høgdall C, Loft A, Berthelsen AK, Høgdall E, Nedergaard L, Lundvall L, Engelholm SA: The diagnostic value of PET/CT for primary ovarian cancer--a prospective study. Gynecol Oncol. 2007, 105 (1): 145-9. 10.1016/j.ygyno.2006.11.022.CrossRefPubMed
15.
go back to reference Ruibal A, Encabo G, Martinéz-Miralles E, Murcia C, Capdevila JA, Salgado A, Martinéz-Vasquéz JM: CA 125 seric levels in non malignant pathologies. Bull Cancer. 1984, 71 (2): 145-6.PubMed Ruibal A, Encabo G, Martinéz-Miralles E, Murcia C, Capdevila JA, Salgado A, Martinéz-Vasquéz JM: CA 125 seric levels in non malignant pathologies. Bull Cancer. 1984, 71 (2): 145-6.PubMed
16.
go back to reference Halila H, Stenman UH, Seppala M: Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy. Cancer. 1986, 57 (7): 1327-9. 10.1002/1097-0142(19860401)57:7<1327::AID-CNCR2820570713>3.0.CO;2-Z.CrossRefPubMed Halila H, Stenman UH, Seppala M: Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy. Cancer. 1986, 57 (7): 1327-9. 10.1002/1097-0142(19860401)57:7<1327::AID-CNCR2820570713>3.0.CO;2-Z.CrossRefPubMed
17.
go back to reference Paavonen J, Miettinen A, Heinonen PK, Aaran RK, Teisala K, Aine R, Punnonen R, Laine S, Kallioniemi OP, Lehtinen M: Serum CA 125 in acute pelvic inflammatory disease. Br J Obstet Gynaecol. 1989, 96 (5): 574-9.CrossRefPubMed Paavonen J, Miettinen A, Heinonen PK, Aaran RK, Teisala K, Aine R, Punnonen R, Laine S, Kallioniemi OP, Lehtinen M: Serum CA 125 in acute pelvic inflammatory disease. Br J Obstet Gynaecol. 1989, 96 (5): 574-9.CrossRefPubMed
18.
go back to reference Jacobs IJ, Skates S, Davies AP, Woolas RP, Jeyerajah A, Weidemann P, Sibley K, Oram DH: Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study. BMJ. 1996, 313 (7069): 1355-8.PubMedCentralCrossRefPubMed Jacobs IJ, Skates S, Davies AP, Woolas RP, Jeyerajah A, Weidemann P, Sibley K, Oram DH: Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study. BMJ. 1996, 313 (7069): 1355-8.PubMedCentralCrossRefPubMed
Metadata
Title
Pelvic mass associated with raised CA 125 for benign condition: a case report
Authors
Viren Asher
Robert Hammond
Tim J Duncan
Publication date
01-12-2010
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2010
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-8-28

Other articles of this Issue 1/2010

World Journal of Surgical Oncology 1/2010 Go to the issue